Core Viewpoint - The article discusses the recent trend of A-share companies terminating major asset restructuring plans, highlighting specific cases such as Chengdu Xian Dao and Guangzhi Technology, which faced significant stock price declines following their announcements [1][4][21]. Group 1: Chengdu Xian Dao - Chengdu Xian Dao announced the termination of its acquisition of a 65% stake in Nanjing Haina Pharmaceutical due to a lack of consensus on key terms among parties involved [5][7]. - Following the announcement, Chengdu Xian Dao's stock price dropped over 3% at the opening on June 30, with a peak decline of over 6% during the morning session [1]. - In the first quarter of 2025, Chengdu Xian Dao reported a revenue of 107 million CNY, a year-on-year decrease of 0.60%, while its net profit increased by 102.90% to 28.28 million CNY [10]. Group 2: Guangzhi Technology - Guangzhi Technology also announced the termination of its acquisition of 100% of Xian Dao Electric Science, which had previously seen its stock rise significantly with eight consecutive "20cm" limit-up days [12][16]. - The company cited changes in external conditions and disagreements on commercial terms as reasons for the termination of the restructuring [16]. - Guangzhi Technology's stock price fell by over 14% following the termination announcement [1]. Group 3: Broader Market Context - Multiple A-share companies, including Chengdu Xian Dao and Guangzhi Technology, have recently announced the termination of restructuring plans, leading to market discussions about the implications of such decisions [21][22]. - Other companies like Chenghe Technology and Yuhongyuan A have also halted their restructuring efforts due to similar issues regarding agreement on core transaction terms [19][20].